![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication June 19, 2007.
Revised July 11, 2007.
Accepted for publication July 12, 2007.
We have previously suggested that the decrease in the levels of serum total thyroxine (T4) and free T4 by a single administration to rats of Kanechlor-500 (KC500) at a dose of 100 mg/kg is not necessarily dependent on the increase in hepatic T4-UDP-glucuronosyltransferase (T4-UDP-GT). In the present study, we determined whether or not a consecutive treatment with KC500 at a relatively low dose (10 mg/kg, i.p., once daily for 10 days) results in decrease in the level of serum total T4 and further investigated an exact mechanism for the KC500-induced decrease in the T4. At 4 days after final treatment with KC500, the serum total T4 and free T4 levels were markedly decreased in both Wistar and UGT1A-deficient Wistar (Gunn) rats, while significant increases in hepatic T4-UDP-GT activity were observed in Wistar rats but not in Gunn rats. Level of serum thyroid-stimulating hormone was not significantly changed in either Wistar or Gunn rats. Clearance from serum of the [125I]T4 administered to the KC500-pretreated Wistar and Gunn rats was faster than that to the corresponding control (KC500-untreated) rats. The accumulated level of [125I]T4 was increased in several tissues, especially the liver, in the KC500-pretreated rats. The present findings demonstrated that a consecutive treatment with KC500 resulted in significant decrease in level of serum total T4 in both Wistar and Gunn rats and further indicated that the KC500-induced decrease would occur through increase in accumulation of T4 in several tissues, especially the liver, rather than increase in hepatic T4-UDP-GT activity.
Key words:
endocrine regulation, environmental toxicology, polycyclic aromatic hydrocarbons, toxicology
This article has been cited by other articles:
![]() |
Y. Kato, K. Haraguchi, M. Kubota, Y. Seto, S.-i. Ikushiro, T. Sakaki, N. Koga, S. Yamada, and M. Degawa 4-Hydroxy-2,2',3,4',5,5',6-heptachlorobiphenyl-Mediated Decrease in Serum Thyroxine Level in Mice Occurs through Increase in Accumulation of Thyroxine in the Liver Drug Metab. Dispos., October 1, 2009; 37(10): 2095 - 2102. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hedge, M. J. DeVito, and K. M. Crofton In Vivo Acute Exposure to Polychlorinated Biphenyls: Effects on Free and Total Thyroxine in Rats International Journal of Toxicology, September 1, 2009; 28(5): 382 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lecureux, M. Z. Dieter, D. M. Nelson, L. Watson, H. Wong, B. Gemzik, C. D. Klaassen, and L. D. Lehman-McKeeman Hepatobiliary Disposition of Thyroid Hormone in Mrp2-Deficient TR- Rats: Reduced Biliary Excretion of Thyroxine Glucuronide Does Not Prevent Xenobiotic-Induced Hypothyroidism Toxicol. Sci., April 1, 2009; 108(2): 482 - 491. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters